Carillion PLC Oman - letter of award for contract (5437W)
15 November 2017 - 6:01PM
UK Regulatory
TIDMCLLN
RNS Number : 5437W
Carillion PLC
15 November 2017
15 November 2017
Carillion Joint Venture signs letter of award for contract in
Oman
Carillion Alawi, a 50:50 Joint Venture with the Zawawi family,
has signed a letter of award with the Oman Ministry of Health as
the preferred bidder in respect of the design and build of the New
Sultan Qaboos Hospital in Salalah. The contract has an estimated
value of cGBP240 million to the Joint Venture.
The contract will consist of a two stage design and build
process. The initial design and mobilisation phase, which will be
directly funded by the customer, will commence immediately. The
second phase would commence in 2018 once the design has been
completed, the contract executed and funding finalised.
A further letter of award is due to be signed shortly by
Carillion Alawi, also with the Oman Ministry of Health, in respect
of a hospital in Khasab. The contract is on similar terms to those
for the Salalah award and, if it were to go ahead, would have an
estimated value of cGBP120m to the Joint Venture.
Both contracts are procured via lower risk procurement routes,
for example through seeking support from UK Export Finance to
secure project finance for customers. The Group continues to look
at ways in which it can de-risk its operations in the Middle East,
working with its partners in the region to secure the future of
this business.
This and other Carillion news releases can be found at
www.carillionplc.com.
For more information
Kellie McAvoy, Head of Investor Relations, or,
John Denning, Director Group Corporate Affairs, Carillion plc
+44 (0) 1902 906333
Teneo Blue Rubicon
Charles Armitstead/Haya Herbert-Burns +44 (0) 207 420 3197
This information is provided by RNS
The company news service from the London Stock Exchange
END
CNTGGGMCGUPMUQA
(END) Dow Jones Newswires
November 15, 2017 02:01 ET (07:01 GMT)
Carillion (LSE:CLLN)
Historical Stock Chart
From Oct 2024 to Nov 2024
Carillion (LSE:CLLN)
Historical Stock Chart
From Nov 2023 to Nov 2024